Skip to content

Study · Non-randomized trial · n = 24 · 1989

3 results

Quality of life assessment before and after growth hormone treatment in adults with growth hormone deficiency.

McGauley GA

Acta paediatrica Scandinavica. Supplement1 Jan 1989Cited by 137 (Europe PMC)

PMID2816361 (opens in a new tab)DOI10.1111/j.1651-2227.1989.tb11249.x (opens in a new tab)PepBankPUB-02816361
Publisher pagePubMedAsk about this study
Jump to 3 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. 3 results from people.

  1. 01HumanNon-randomized trialEfficacy outcome

    In GH-deficient adults, preliminary analysis showed less perceived illness after 6 months with hGH than placebo.

    In plain wordsIn GH-deficient adults, preliminary analysis showed less perceived illness after 6 months with hGH than placebo.

    Peptide
    HGH (somatotropin)
    Outcome
    DecreasePerceived illness
    Study

    n = 24

    Comparator
    Placebo
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated · 6 monthsAs given in this study (human).

    Source sentences

    Summary
    Preliminary analysis of the results shows that after 6 months patients receiving human growth hormone (hGH) treatment experienced less perceived illness than the placebo group.
    2 context sentences
    Summary · context
    The effect of recombinant human growth hormone (rhGH) treatment on the quality of life was studied in adults with growth hormone deficiency (GHD).
    Summary · context
    Twenty-four adults who satisfied strict criteria for GHD took part in a double-blind, placebo-controlled, 6-month trial.
  2. 02HumanNon-randomized trialEfficacy outcome

    In GH-deficient adults, hGH significantly improved perceived energy versus placebo.

    In plain wordsIn GH-deficient adults, hGH improved perceived energy compared with placebo.

    Peptide
    HGH (somatotropin)
    Outcome
    IncreasePerceived energy
    Study

    n = 24

    Comparator
    Placebo
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated · 6 monthsAs given in this study (human).

    Source sentences

    Summary
    Significant psychological improvement was noted in the hGH-treated patients' perception of their energy level and mood compared to the placebo group.
    2 context sentences
    Summary · context
    The effect of recombinant human growth hormone (rhGH) treatment on the quality of life was studied in adults with growth hormone deficiency (GHD).
    Summary · context
    Twenty-four adults who satisfied strict criteria for GHD took part in a double-blind, placebo-controlled, 6-month trial.
  3. 03HumanNon-randomized trialEfficacy outcome

    In GH-deficient adults, hGH significantly improved mood versus placebo.

    In plain wordsIn GH-deficient adults, hGH improved mood compared with placebo.

    Peptide
    HGH (somatotropin)
    Outcome
    IncreaseMood
    Study

    n = 24

    Comparator
    Placebo
    Outcome group
    Anxiety and mood · Mental health and mood
    Studied dose
    Dose not stated · 6 monthsAs given in this study (human).

    Source sentences

    Summary
    Significant psychological improvement was noted in the hGH-treated patients' perception of their energy level and mood compared to the placebo group.
    2 context sentences
    Summary · context
    The effect of recombinant human growth hormone (rhGH) treatment on the quality of life was studied in adults with growth hormone deficiency (GHD).
    Summary · context
    Twenty-four adults who satisfied strict criteria for GHD took part in a double-blind, placebo-controlled, 6-month trial.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    28 Oct 2026, 02:03 UTC

    Study results updated

  2. Version 1

    27 Oct 2026, 16:37 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.